PERCEPTIONS DATA
Friday, February 1, 2013
Bristol-Myers Squibb's revenue falls by 23% on patent expiration
Bristol-Myers Squibb's revenue falls by 23% on patent expiration
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment